Combining proteomics and genetic screens to identify KRAS synthetic lethal interactions.

被引：0
|
作者：
Sheth, S. [1 ,2 ]
Cook, Danielle R. [1 ,2 ]
Strasser, Samantha D. [3 ]
Martin, Timothy D. [4 ]
Menon, Sneha [1 ,2 ]
Popow, Olesja [1 ,2 ]
Paulo, Joao A. [1 ,2 ]
Elledge, Steve J. [4 ]
Haigis, Kevin M. [1 ,2 ]
机构：
[1] Harvard Med Sch, Canc Res Inst, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Med, Boston, MA 02115 USA
[3] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[4] Harvard Univ, Sch Med, Program Virol, Boston, MA USA
来源：
MOLECULAR CANCER RESEARCH | 2020年 / 18卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B09
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [1] Genetic and environmental context dependency confounds identification of KRAS synthetic lethal interactions.
    Ku, Angel
    Hu, Hsien-Ming
    Kongara, Sameera
    Zhao, Xin
    Di, Wu
    McCormick, Frank
    Balmain, Allan
    Bandyopadhyay, Sourav
    MOLECULAR CANCER RESEARCH, 2020, 18 (05) : 72 - 72
  • [2] Chemical-genetic Screens for Synthetic Lethal Interactions in Pancreatic Ductal Adenocarcinomas
    Caffa, I.
    Soncini, D.
    Ansaldi, F.
    Provenzani, A.
    Castiglioni, I.
    Patrone, F.
    Ballestrero, A.
    Nencioni, A.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 52 - 52
  • [3] Viability screens in cancer cells with pooled shRNA libraries identify potential therapeutic targets and synergistic lethal interactions.
    Tedesco, D.
    Bonneau, K.
    Makhanov, M.
    Frangou, G.
    Chenchik, A.
    MOLECULAR BIOLOGY OF THE CELL, 2011, 22
  • [4] Systematic yeast synthetic lethal and synthetic dosage lethal screens identify genes required for chromosome segregation
    Measday, V
    Baetz, K
    Guzzo, J
    Yuen, K
    Kwok, T
    Sheikh, B
    Ding, HM
    Ueta, R
    Hoac, T
    Cheng, B
    Pot, I
    Tong, A
    Yamaguchi-Iwai, Y
    Boone, C
    Hieter, P
    Andrews, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (39) : 13956 - 13961
  • [5] Integration of centrosomeassociated and kinase-related screens to identify centrosome amplification -related synthetic lethal interactions
    Drosopoulos, Konstantinos
    Scott, Carly
    Tang, Chan
    Linardopoulos, Spiros
    CANCER RESEARCH, 2012, 72
  • [6] Validation of computationally predicted synthetic lethal interactions for KRAS.
    Gong, He
    Repellin, Claire
    Patel, Puja
    Knapp, Merrill
    He, Mingze
    Li, Jun
    Wu, Lisa
    Liu, Xiaohe
    Sinha, Subarna
    Sambucetti, Lidia
    CANCER RESEARCH, 2021, 81 (13)
  • [7] CRISPR screens to identify novel DNA repair defects synthetic lethal therapies
    Durocher, D.
    CANCER RESEARCH, 2022, 82 (04)
  • [8] High-throughput drug screens identify novel synthetic lethal interactions with MLH1-deficient cancers
    Hewish, Madeleine
    Lord, Chris J.
    Martin, Sarah A.
    Cunningham, David
    Ashworth, Alan
    CANCER RESEARCH, 2011, 71
  • [9] Comparative genomics as a tool for the identification of novel Kras synthetic lethal interactions
    Sweet-Cordero, Alejandro
    CANCER RESEARCH, 2011, 71
  • [10] Minimized combinatorial CRISPR screens identify genetic interactions in autophagy
    Diehl, Valentina
    Wegner, Martin
    Grumati, Paolo
    Husnjak, Koraljka
    Schaubeck, Simone
    Gubas, Andrea
    Shah, Varun Jayeshkumar
    Polat, Ibrahim H.
    Langschied, Felix
    Prieto-Garcia, Cristian
    Muller, Konstantin
    Kalousi, Alkmini
    Ebersberger, Ingo
    Brandts, Christian H.
    Dikic, Ivan
    Kaulich, Manuel
    NUCLEIC ACIDS RESEARCH, 2021, 49 (10) : 5684 - 5704
12345